Crash Course in Cures: Bone Marrow Biopsies in AML Clinical Utility image

Crash Course in Cures: Bone Marrow Biopsies in AML Clinical Utility

Jun 16, 2026
11:00AM - 12:00PM EDT
Online Event
Overview

Bone Marrows biopsies can bring lots of questions and concerns. Hear from Dr.Douglas Tremblay as he discusses the use of bone marrow biopsies in FLT3 Mutant AML.There will be a Q&A session at the end so come with questions!

Agenda
11:00 AM
Introduction
Eliza Prickett

Eliza introduces the agenda for the event and featured speaker Dr. Douglas Tremblay

11:05 AM
Presentation
Douglas Tremblay, MD

Hear from Dr.Douglas Tremblay as he discusses the use of bone marrow biopsies in FLT3 Mutant AML.

11:35 AM
Questions and Answers
Audience

Type your questions in the chat and we will answer them! 

Speakers & Moderators
Healthtree contact Eliza Prickett

Eliza Prickett

Eliza joined HealthTree in March 2026 as the Leukemia Patient Health Education Manager. Prior to joining HealthTree, she completed a Master’s Degree in Public Health from Brigham Young University and worked with a variety of underserved populations in government and healthcare settings, including Americorps and Utah Health Department. When not in office, Eliza enjoys reading, writing and learning new things about the world.
Healthtree contact Douglas Tremblay, MD

Douglas Tremblay, MD

Dr. Tremblay has led multi-institutional research efforts in myeloproliferative neoplasms and is actively involved in both investigator-initiated and industry sponsored early and late phase clinical trials in myeloid neoplasms. Dr. Tremblay specializes in hematologic malignancies including acute myeloid leukemia, myeloproliferative neoplasms and myelodysplastic syndromes.